Recent News
Dartmouth Researcher, Dr. Juliette Madan, has received the Harry Shwachman Award from the Cystic Fibrosis Foundation
February 19, 2012
Dr. Juliette Madan has received the prestigious Harry Shwachman Cystic Fibrosis Clinical Investigator Award from the Cystic Fibrosis Foundation. The award provides salary support for three years and is for promising, clinically trained physicians who are committed to developing their CF-related research.
FDA Approves Vertex Cystic Fibrosis Drug
January 31, 2012
Health regulators approved Vertex Pharmaceuticals' Kalydeco, the first drug designed to treat the underlying cause of cystic fibrosis, a rare genetic disease. Bruce Stanton, Ph.D., Director of the Dartmouth CF Research Development Program, and Director of the Dartmouth Lung Biology Center, was a consultant for the CF Foundation in their collaboration with Vertex to develop this life saving drug.
For more information click here
Dartmouth Researcher, George O'Toole, named a Fellow by the American Association for the Advancement of Science
November 22, 2011
The American Association for the Advancement of Science (AAAS) has elevated George O'Toole to the rank of Fellow. Dr. O'Toole is a Dartmouth Medical School professor of Microbiology and Immunology and is the Associate Director of the CF Research Development Program at DMS. He was elected by his peers as part of the section on biological sciences for outstanding contributions to understanding how the pathogen Pseudomonas aeruginosa infects the lungs in individuals with cystic fibrosis.
First Annual Dartmouth Cystic Fibrosis Scientific Retreat
October 11, 2011
On Oct. 6 the Dartmouth Lung Biology Center and the CF Research Development Program sponsored the first annual Dartmouth CF Scientific retreat. 69 scientists and trainees from Dartmouth, Harvard, Massachusetts General Hospital, the University of Vermont, the University of Maine, as well as Novartis, Genzyme, and Flatley Drug Discovery attended the day long scientific retreat. Talks were presented on Pseudomonas infection of the airways, CF drug discovery, and translational CF research. The format of the meeting enhanced interactions and the meeting culminated in a dinner followed by a poster session.
DMS students travel Down East to study molecular mechanisms of human disease
August 16, 2011
Under the guidance of Dartmouth microbiologist Bruce Stanton, PhD, four students from Dartmouth Medical School (DMS) spent the first week of August researching triggers of human disease at the Mount Desert Island Biological Laboratory (MDIBL).
Full Story
Cystic Fibrosis Foundation funds lung-disease research at Dartmouth
May 5, 2011
Under a four-year grant of almost $1.4 million from the Cystic Fibrosis Foundation, veteran researcher Bruce A. Stanton, Ph.D., will lead a team of Dartmouth investigators in developing new approaches to treatment of patients with the genetic disease that triggers chronic and life-threatening infection of the lungs.
Hitchcock Foundation funds lung-disease project
April 29, 2011
With support from the Hitchcock Foundation's inaugural Program Project Grant (HF-PPG), biochemist Dean R. Madden, PhD, will lead a diverse team of Dartmouth researchers in the search for clues to how bacterial and fungal infections conspire to clog the breathing systems of patients with maladies such as cystic fibrosis.
Full Story
